Kinki University
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1943-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.kindai.ac.jp
Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis
Phase 2
- Conditions
- First Posted Date
- 2010-10-22
- Last Posted Date
- 2011-07-22
- Lead Sponsor
- Kinki University
- Target Recruit Count
- 20
- Registration Number
- NCT01226147
- Locations
- 🇯🇵
Kinki University Hospital, Osaka, Japan
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer
Phase 1
Completed
- Conditions
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2012-04-06
- Lead Sponsor
- Kinki University
- Target Recruit Count
- 9
- Registration Number
- NCT00845611
- Locations
- 🇯🇵
department of surgery, Kinki University, Osakasayama, Osaka, Japan
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer
Phase 1
Completed
- Conditions
- First Posted Date
- 2008-09-17
- Last Posted Date
- 2012-04-06
- Lead Sponsor
- Kinki University
- Target Recruit Count
- 7
- Registration Number
- NCT00753844
- Locations
- 🇯🇵
department of surgery, Kinki University, Osakasayama, Osaka, Japan
© Copyright 2024. All Rights Reserved by MedPath